Scientific Program


The program of the 11th World Congress on Alternatives and Animal Use in the Life Sciences (WC11) will be virtual due to continued COVID-19 imposed restrictions, and will be spread over a two-week period, from 23 August - 2 September 2021.

The program below is subject to change. The final program will be available in June 2021.

Monday 23 August 2021 - Day 1

1.45 - 3.30 PM - Plenary sessions

1.45 - 2.15 PM

WC11 Virtual Opening Ceremony and Welcome Address

The official opening of the WC11 Virtual Congress with speeches from the Chair of the Local Organizing Committee, President of the Maastricht University and a representative of the European Commission. With a real Maastricht, the Netherlands flavor. 

2.15 - 3.15 PM

KEYNOTE: Dr. André Kuipers, European Space Agency

Born on 5 October 1958 in Amsterdam, the Netherlands, André Kuipers is married with three daughters and a son. He enjoys flying, scuba diving, skiing, hiking, traveling, and history.

In December 2002, André was assigned as a Flight Engineer for a Soyuz flight to the International Space Station. The DELTA mission was sponsored by the Dutch government in an agreement between ESA and the Russian Federal Space Agency and took place from 19–30 April 2004. The flight had three objectives: to exchange the Soyuz spacecraft that serves as Space Station lifeboat, to exchange the Station crew and for André to perform 21 experiments in human physiology, biology, technology and education.

In August 2009, André was assigned to Expedition 30/31, a long-duration mission to the International Space Station called PromISSe. Together with Russian cosmonaut Oleg Kononenko and NASA astronaut Don Pettit, André was launched on 21 December 2011 from Baikonur Cosmodrome in Kazakhstan. During his mission, he took part in around 50 experiments covering a wide range of disciplines. He was the prime crewmember for the rendezvous and docking of ESA’s third Automated Transfer Vehicle. He was also involved in berthing SpaceX’s Dragon ferry. André and his crewmates returned to Earth on 1 July 2012.

Read more about André Kuipers on the  website of the European Space Agency.

3:15 - 3.30 PM

Break and WC11 TV from the studio

3.30 - 5.30 PM - Parallel Session MO-1

3.30 - 5.30 PM

S21: Remove ATT, TABST & LABST. How far away we are to global harmonization for those safety tests? (Theme: Disease)

Chair: L. Viviani, Humane Society International

Session info

Many institutions and organization have been working independently or jointly to remove those obsolete safety testing from the production and batch release testing for human (ATT) and veterinary vaccines (TABST, LABST). Many regulatory agencies and international organizations have successfully removed or suggested the remove or the waiver of those tests. How far away are we from their global elimination?


3.30 - 3.45 PM: Global Roadmap to remove ATT, TABST, LABST. HSI collaboration with multiple international stakeholders - L. Viviani, Humane Society International

3.45 - 4.00 PM: European experience in removing ATT, TABST and LABST - Joint collaboration among stakeholders - K. Schutte, EPAA - European Partnership for Alternative Approaches to Animal Testing

4.00 - 4.15 PM: TABST & LABST waiver. The perspective of veterinary vaccines manufacturers - C. Philippe, Boehringer Ingelheim

4.15 - 5.00 PM: The Brazilian perspective on the future of TABST and LABST - M. Vinicius de Santana Leandro, Ministry of Agriculture Brazil

5.00 - 5.15 PM: Removal of General Safety Testing from veterinary vaccines in India - B. Poojari, HSI/India

5.15 - 5.30 PM: Removal of General Safety Testing from human vaccines in India: a successful approach - S. K. Goel, Serum Institute of India

3.30 - 5.30 PM

S200: Establishing a European Network of 3Rs Centers and 3Rs-Societies (Theme: Ethics, Welfare and Regulation)

H. Spielmann, EUSAAT (European Society for Alternatives to Animal Testing)

3.30 - 5.30 PM

S167: Replacing Fetal Bovine Serum (FBS) – Innovative Alternatives and Transition Strategies (Theme: Innovative Technologies)

T. Weber, German Animal Welfare Federation / Animal Welfare Academy

3.30 - 5.30 PM

S161: Validation redefined: needs and opportunities for the validation of (r)evolutionary non-animal approaches for chemical safety assessment (Theme: Safety)

A.Piersma, National Institute for Public Health and the Environment

3.30 - 5.30 PM

S149: Implementing openness: promoting transparency around animal research across regions (Theme: Ethics, Welfare and Regulation)

B. Williams, Understanding Animal Research 

3.30 - 5.30 PM

S79: Methods to enhance biotransformation capability for in vitro high throughput screening assays (Theme: Safety)

M. Xia, SOT/National Center for Advancing Translational Sciences

5.30 - 7.00 PM - Plenary sessions

5.30 - 5.45 PM

Break and WC11 TV from the studio

5.45 - 6.45 PM

KEYNOTE: Russel Thomas

6.45 - 7.00 PM

Break and WC11 TV from the studio

7.00 - 9.00 PM - Parallel Session MO-2

7.00 - 9.00 PM

S71: Biomarker-based in vitro tools targeting early Alzheimer's in a human relevant fashion (Theme: Disease)

E. Roggen, ToxGenSolutions BV

7.00 - 9.00 PM

S76: Sharing organs and tissues to reduce the lab animal usage – Current update on existing biobanks and sharing platforms (Theme: Ethics, Welfare and Regulation)

A. Lang, Charité-Universitätsmedizin Berlin

7.00 - 9.00 PM

S235: Case studies of industrial adoption using Microphysiological Systems (Theme: Innovative Technologies)

A. Roth, Hoffman La Roche

7.00 - 9.00 PM

S163: New Approach Methodologies (NAM)-supported Read-Across Approaches for Regulatory Purposes (Theme: Safety)

G. Pallocca, CAAT-Europe

7.00 - 9.00 PM

S196: Barriers of Refinement Use in Practice (Theme: Ethics, Welfare and Regulation)

C. Schuppli, University of British Columbia

7.00 - 9.00 PM

S111: Modern, Mechanistic Approaches to Cancer Risk Assessment (Theme: Safety)

G. Hilton, PETA International Science Consortium Ltd.

9.00 - 10.00 PM - WC11 Talkshow live from the studio in Maastricht

9.00 - 10.00 PM

WC11 Talkshow live from the studio